Edema News and Research

RSS
Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.
iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Pycnogenol can improve microcirculation, retinal edema and visual acuity, reveals study

Pycnogenol can improve microcirculation, retinal edema and visual acuity, reveals study

New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathy

New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathy

Burrill Biotech Select Index manages to claw back almost half the value it lost in October

Burrill Biotech Select Index manages to claw back almost half the value it lost in October

J&JPRD submits an NDA for tapentadol ER tablets

J&JPRD submits an NDA for tapentadol ER tablets

FDA grants approval for Dyax' KALBITOR for treating HAE patients

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Amgen to present updated data on Nplate at the 2009 ASH meeting

Amgen to present updated data on Nplate at the 2009 ASH meeting

High levels of physical activity may damage knees and increase risk for osteoarthritis

High levels of physical activity may damage knees and increase risk for osteoarthritis

iCo Therapeutics reports financial results for three months ended September 30, 2009

iCo Therapeutics reports financial results for three months ended September 30, 2009

Tibotec Therapeutics'  INTELENCE granted FDA traditional approval

Tibotec Therapeutics' INTELENCE granted FDA traditional approval

FDA approves Berinert for treating HAE in adults and adolescents

FDA approves Berinert for treating HAE in adults and adolescents

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

NeoPharm presents LE-DT Phase I data at the AACR conference

NeoPharm presents LE-DT Phase I data at the AACR conference

Levulan PDT may reduce the rate of recurrence of SCCs in solid organ transplant recipients: Study

Levulan PDT may reduce the rate of recurrence of SCCs in solid organ transplant recipients: Study

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented